Business Wire

ROKA Launches Ultralight Advanced Performance Eyewear with World-Class Roster of Athletes

13.3.2018 22:36:00 EET | Business Wire | Press release

Share

ROKA Sports Inc., the Austin, TX based performance multisport company, has announced the release of its new Advanced Performance for Extreme Conditions (A.P.EX) line of eyewear. The collection was designed from scratch for the athlete who requires maximum field of view, protection, ultra-lightweight, and seamless fit and retention. The Advanced Performance collection is incredibly versatile, coming in five styles and up to ten lens tint options, so athletes can completely customize their eyewear to meet their specific needs.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20180313006426/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

(Photo: Business Wire)

The unique design of ROKA’s Advanced Performance collection is the realization of more than two years of stealth R&D by ROKA’s eyewear division, an all-star team of designers and engineers based in Irvine, California, who were assembled specifically for this mission and were drawn from Apple, Oakley, Under Armour, and other leading brands. Upon formation, ROKA Co-Founders Rob Canales and Kurt Spenser challenged the team, which has over 110 years combined experience making performance eyewear, to design and build the best sport optics on the planet from the inside out, with a primary focus on function in extreme conditions.

“This is truly a breakthrough in performance eyewear,” says ROKA Co-Founder and CEO Rob Canales. “We build products for the most demanding athletes in the world, and through meticulous attention to detail and the aggregation of incremental gains, our team has delivered. While other brands are cutting performance and quality to satisfy their monopolist owners, we’ve gone all in with a truly independent line that is with uncompromising performance.”

The A.P.EX line consists of three different frame options, with multiple lens height configurations: The SL-1, SL-1x, SR-1, SR-1x, and TL-1. Weighing in at only 21 – 25 grams, every style features ultra-lightweight materials and construction without compromising durability. An adjustable titanium core offers a customized fit, and advanced materialization with ROKA’s patented GEKO™ technology on the nose pads and temples ensure a rock solid fit under the most adverse training and racing conditions.

All five styles feature premium nylon lens options by Carl Zeiss Vision that come standard with market-leading hydrophobic, oleophobic, anti-scratch, anti-fog, and anti-reflectance coatings. Whether riding in the glaring sun or running through rain and snow, athletes will have multiple contrast and mirror options for the specific demands of the day.

“The moment I slipped on the ROKA sunglasses, I knew they had set a new standard in the performance eyewear market,” says eight-time triathlon world champion Javier Gómez. “There is nothing else that comes close in terms of weight, security, and optics. ROKA’s technical apparel and goggles have been a secret weapon for me in multiple world championships. I’m thrilled to have that same world-beating standard for my eyewear.”

Gómez is one of more than 40 elite athletes to debut the Advanced Performance eyewear in 2018. Regardless of the arena or challenge, ROKA eyewear is designed for athletes seeking to redefine standards, to break barriers, and to find every advantage possible. Within a few weeks of their release, Carlos Sainz drove them to victory at the Dakar Rally in South America, and Esmee Visser took them to the top of the Olympic podium in speed skating in PyeongChang.

“I first tried ROKA sunglasses in January—about a month before the Olympics,” Visser says. “The sunglasses I used previously were good, but I always had problems with my eyes tearing up. With ROKA’s SR-1 sunglasses, I had better protection and fewer tears, and they weighed less, so it was an easy decision to use them at the Olympics.”

Advanced Performance optics have also helped pro cyclists Bryan Coquard and Magnus Cort Nielsen reach the top of the World Tour podium in 2018, out-sprinting the best cyclists in the world. They will also be the eyewear of choice for Dan Martin this July when he attempts to become the second Irishman ever to win the Tour de France.

“I pride myself on being innovative and finding every little advantage that I can,” says Martin. “When I looked into the ROKA brand, I knew they fit with my philosophy.” Martin says. “From the moment I put on the Advanced Performance eyewear, I knew ROKA had designed something truly better. The weight and fit is unlike anything else I’ve ever tried.”

Remaining true to its DNA as the top endurance sports brand in the world and its roots as the leading high-performance triathlon brand, a large number of triathletes including Ironman Linsey Corbin, the fastest American woman at the Iron distance, have chosen ROKA as their eyewear partner for the hardest single-day endurance event in the world, joining Gómez and original ROKA athlete Jesse Thomas.

The mission to create the most advanced high-performance eyewear on the planet began with the challenge presented by ROKA’s first sponsored athlete, Jesse Thomas, who wanted to blend his classic style of retro aviators with the lightweight fit and protection of high-performance optics.

“We’re passionate about designing the most advanced high performance products on the market for athletes who seek to redefine the standard. We are a dedicated team of creators, designers, engineers, and athletes who share that mission. We are incredibly proud of the results thus far. Stay tuned.” says ROKA Co-Founder and Chief Creative Officer, Kurt Spenser. “This incredible group of athletes all share a commitment to perform at the highest level in their respective arenas, and to go beyond what was previously thought possible. We work tirelessly to honor that commitment by delivering the most advanced eyewear in the world.”

Each of the five styles in the Advanced Performance collection has been optimized for specific use cases to accommodate a range of fit and function preferences. With its rimless design, the SL-1 and SL-1x provide athletes a completely unobstructed field of view and venting, even while in the extreme forward aero position under the hottest conditions. The SR-1 and SR-1x are designed for security, confidence, and speed for the absolutely fastest training and racing days, and they’re equally as comfortable underneath a helmet as they are out on the run. The sleek and stylish TL-1 is a high-performing, twin-lens sport frame that offers versatility, security, and ultralight performance, and is sure to be an instant favorite across a variety of applications.

All five styles feature ROKA’s patented GEKO™ pads on the nose and temples for optimal traction and comfort, as well as titanium core wires in the temples to provide a customized fit for every athlete. The SL-1, SL-1x, SR-1 and SR-1x feature nine interchangeable accessory lens options, so athletes can quickly change the tint to take on the specific conditions of any ride, run or race. The polarized lens options in the TL-1 are cut for superior optics and exceed all industry standards for polarization efficiency. ROKA’s proprietary polarization process minimizes distortion and warpage better than any other eyewear on the market.

“When we debuted our first line of eyewear in 2016, we sought to be the first brand to blend classic optical style with high performance and comfort,” said James Oman, Vice President of Engineering. “With the Advanced Performance line, we are pushing beyond limits to create a new standard of optics, protection and versatility. It’s a bold new category of eyewear that will forever change what athletes expect from a pair of sunglasses.”

About ROKA

ROKA started in a garage in Austin, Texas with humble beginnings and laser-beam focus. Our mission is to unlock human potential. To equip, empower, inspire and ignite. We serve those who seek to redefine the standard, to push themselves to the limit – whatever and wherever that may be. When we see an opportunity to innovate, to challenge the status quo, to disrupt a complacent or monopolistic market, we go all in.

Since our launch in 2013, our athletes have won over a dozen world titles and have been instrumental in the design and development of our patented and award-winning products. In 2016, we were proud to send 18 athletes to the Rio Olympics, and even prouder to take home Gold and Bronze. This year in PyeongChang, we continued the tradition, with ROKA athletes taking home Olympic Gold and Bronze in our most cutting edge products.

With our debut eyewear collection in late 2016, we have set a new bar by making ultralight performance eyewear with zero compromise on style, and with a patented design for sunglasses that stay put on your face even during the most extreme training and racing. Featuring a suite of the world's most advanced materials and patented technologies, our award-winning Ultralight Performance Eyewear delivers on our promise to create the finest technical equipment on the planet, full stop. For more information, visit www.roka.com/pages/contact-us.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

ROKA
Diane Thibert
VP Communications & Public Relations
(310) 804-2400
diane@roka.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye